MetaVia Inc. (Nasdaq: MTVA) (MetaVia or the Company), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced the closing of its previously announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback